Related references
Note: Only part of the references are listed.Mutation-specific downregulation of CFTR2 variants by gating potentiators
Radu G. Avramescu et al.
HUMAN MOLECULAR GENETICS (2017)
Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations
Robert M. Vernon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Xuefeng Liu et al.
NATURE PROTOCOLS (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
Miklos Bagdany et al.
NATURE COMMUNICATIONS (2017)
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
Iwona M. Pranke et al.
SCIENTIFIC REPORTS (2017)
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A. Tosco et al.
CELL DEATH AND DIFFERENTIATION (2016)
Analysis of nasal potential in murine cystic fibrosis models
Melanie Faria da Cunha et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy
Justin D. Hall et al.
PROTEIN SCIENCE (2016)
Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
Guido Veit et al.
PLOS BIOLOGY (2016)
Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27
Miqueias Lopes-Pacheco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Restoration of NBD1 Thermal Stability Is Necessary and Sufficient to Correct ΔF508 CFTR Folding and Assembly
Lihua He et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR
Agata M. Trzcinska-Daneluti et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
ΔF508 CFTR interactome remodelling promotes rescue of cystic fibrosis
Sandra Pankow et al.
NATURE (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
Ramanath Narayana Hegde et al.
ELIFE (2015)
Cystic fibrosis genetics: from molecular understanding to clinical application
Garry R. Cutting
NATURE REVIEWS GENETICS (2015)
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
Fredrick Van Goor et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508-CFTR Protein Trafficking
Keith C. Coffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Guido Veit et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Deborah M. Cholon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding
Daniela Martino Roth et al.
PLOS BIOLOGY (2014)
Synergy-Based Small-Molecule Screen Using a Human Lung Epithelial Cell Line Yields ΔF508-CFTR Correctors That Augment VX-809 Maximal Efficacy
Puay-Wah Phuan et al.
MOLECULAR PHARMACOLOGY (2014)
Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
Carlos M. Farinha et al.
CHEMISTRY & BIOLOGY (2013)
Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane
Pirjo M. Apaja et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay et al.
NATURE GENETICS (2013)
Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
Emilie Lyne Saussereau et al.
PLOS ONE (2013)
The CFTR Ion Channel: Gating, Regulation, and Anion Permeation
Tzyh-Chang Hwang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
Juan L. Mendoza et al.
CELL (2012)
Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
Wael M. Rabeh et al.
CELL (2012)
V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists
Kazuhiro Takahashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity
Stefania Monterisi et al.
JOURNAL OF CELL SCIENCE (2012)
Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
Guido Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Small-molecule proteostasis regulators for protein conformational diseases
Barbara Calamini et al.
NATURE CHEMICAL BIOLOGY (2012)
Protein quality control at the plasma membrane
Tsukasa Okiyoneda et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea
Wan Namkung et al.
FASEB JOURNAL (2010)
CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners
Chunying Li et al.
INTEGRATIVE BIOLOGY (2010)
The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
Patrick H. Thibodeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Quality control for unfolded proteins at the plasma membrane
Pirjo M. Apaja et al.
JOURNAL OF CELL BIOLOGY (2010)
Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2010)
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Tsukasa Okiyoneda et al.
SCIENCE (2010)
Cooperative Assembly and Misfolding of CFTR Domains In Vivo
Kai Du et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation
Luisa S. Pissarra et al.
CHEMISTRY & BIOLOGY (2008)
Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects
Anna Duarri et al.
HUMAN MOLECULAR GENETICS (2008)
Processing and function of CFTR-ΔF508 are species-dependent
Lynda S. Ostedgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Additive effect of multiple pharmacological chaperones on maturation of CFTR processing mutants
Ying Wang et al.
BIOCHEMICAL JOURNAL (2007)
Domain interdependence in the biosynthetic assembly of CFTR
Liying Cui et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive
Tamas Hegedus et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-
C Ehrhardt et al.
CELL AND TISSUE RESEARCH (2006)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
K Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Share Paper
